chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a health care professional on 28 August 2007. A 12-year-old male patient, with a history of pre-existing latex allergy, had received an injection of Menactra (route, site and lot number not reported) on 28 August 2007 and an unspecified period of time later experienced shortness of breath, hives, and throat swelling leading to an emergency room visit. The reporter stated that the patient had returned to the office with anaphylaxis. The patient's recovery status was unknown at the time of the report.
arm hurt pretty bad; This case was reported by a consumer and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient recently received the first Shingrix. The patient's arm hurt pretty bad. The second shot was everything which was described for about a week. The patient was glad that he/she had got the shots because of the horrible things the patient had heard about shingles. This case was linked with US2021AMR188036, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR188036:
Fine the day of vaccination, just a little sore. The next morning, swollen red patch on arm at site. That evening, red patch is not better, firm lump underneath skin. Tender out of proportion to how I usually react to vaccines.
Information has been received from a nurse concerning an 80 year old male with an allergy to tetanus vaccine, who in October 2007, was vaccinated with a dose of ZOSTER subcutaneously. In September 2008 (this week), the patient developed shingles across her lower back after administration of vaccine. The patient had "a lot of lesions". The nurse was not interested in VZV analysis by(polymerase chain reaction) PCR. The patient sought medical attention with an office visit. At the time of reporting, the patient had not recovered. This is on of two reports from the same source. Additional information is not expected.
41 y/o female reports tingling sensation in left arm, radiating down to fingertips approximately 10 minutes after receiving the Moderna (Covid-19) vaccine in left deltoid. Pt alert and oriented x4, speaks in clear and complete sentences. Pt denies any CP, sob, or pain.  Pt assessed by provider informed to monitor patient. Pt now verbalizes tingling sensation in arm has subsided. Pt with new onset of seeing dark spots in visual field intermittently feels cold, and weak.  Pt denies headache, nausea, dizziness or any pertinent medical history. Pt only eaten a banana earlier today BS 101. Provider informed as noted above, pt. cleared to leave given work note thru 05/13/2021. Pt informed, if worsening sxs, go to the ER. Pt now c/o feeling faint and weak. Vitals retaken BP 109/79, R20, P74, O2sat 99%. Pt informed to go to ER. Pt informed to have someone drive her now. She states co-worker will drive her. Pt prefers to go home and rest. Pt informed official recommendation is to go to ER for further evaluation. Pt agrees and verbalizes understanding.
her lymphedema on her right arm became a cellulitis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CELLULITIS (her lymphedema on her right arm became a cellulitis) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Lymphedema (lymphedema on her right arm for several years). Concomitant products included ALENDRONATE SODIUM (ALENDRONATE), ATENOLOL, FLUOXETINE, ISOSORBIDE MONONITRATE, RANOLAZINE, NIACIN, METFORMIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), SIMVASTATIN and TRAZODONE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced CELLULITIS (her lymphedema on her right arm became a cellulitis) (seriousness criterion medically significant). At the time of the report, CELLULITIS (her lymphedema on her right arm became a cellulitis) had resolved. Not Provided          As treatment took antibiotics (Doxycycline Monohydrate 100 mg) for 10 days.  Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
chronic migraines few did not follow her typical migraine pattern; Itchy Injection Site; Sore Injection Site; Swollen Injection Site; Red Injection Site; Muscle Ache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (chronic migraines few did not follow her typical migraine pattern), VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE PAIN (Sore Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site) and VACCINATION SITE ERYTHEMA (Red Injection Site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Chronic migraine.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy Injection Site), VACCINATION SITE PAIN (Sore Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and MYALGIA (Muscle Ache). On an unknown date, the patient experienced MIGRAINE (chronic migraines few did not follow her typical migraine pattern). On 15-Mar-2021, VACCINATION SITE PAIN (Sore Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE ERYTHEMA (Red Injection Site) and MYALGIA (Muscle Ache) had resolved. At the time of the report, MIGRAINE (chronic migraines few did not follow her typical migraine pattern) outcome was unknown and VACCINATION SITE PRURITUS (Itchy Injection Site) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 90 (Low) 90 Percent.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Reporter details, Patient's medical history, lab data and event data  has been updated.
A CONSTANT HEADACHE , SEVERE PAIN ON LEFT ARM WITH A 3 1/2 INCH ROUND BRIGHT RED CIRCLE, VERY HARD. SEVERE PAIN IN LEFT ARM. LEFT SIDE OF FACE IS VERY TEDER TO TOUCH.
Patient complained of dizziness shortly after vaccine administration.  Shortly thereafter, rash developed around chest, down left arm.  Check BP x2 410 pm 149/92, 414PM 157/96 Gave 50 mg benadryl 414pm . Patient never had any respiratory distress.  Patient left on own accord.  Rash resolved about 20 minutes after benadryl given. patient reported fatigue, headache.
after first dosea red prickly feeling rash with asandpaper.in a few days it moved to myshoulders..after a few more days itmoved to my inner thigh...two daysago it moved to my face...one day ago it moved to my neck.; red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to  shoulders, inner thigh, face, neck/ red mottled rash not going away; red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to  shoulders, inner thigh, face, neck/ red mottled rash not going away; after first dose a red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on my upper arms..in a few days it moved to my shoulders..after a few more days it moved to my inner thigh...two days ago it moved to my face; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 24Feb2021 at 08:45 (at the age of 62-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 16Mar2021 at 14:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, immunoglobulin E high and outdoor and environmental allergies. Concomitant medications included thyroid (ARMOUR THYROID) 120 mg and omalizumab (XOLAIR) twice per month for elevated IGE. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/red mottled rash not going away. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with doxycycline for sores and hydrocortisone ointment for rash. The clinical outcome of the events red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/ red mottled rash not going away was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 50-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 23-JAN-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-APR-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
Patient started feeling really nauseous after receiving the vaccine and had to lay down for about 15 minutes and drink some water. Patient did not need any medical attention. Patient had to call her husband to come and get her. Patient attributed it to her fear of needles.
HA, temp of 104.8, B/P 168/80, ache all over-lasted for 24 hrs.
Initial and follow-up information has been received from a licensed practical nurse concerning a 39 year old female homemaker with no medical history and allergies to erythromycin and codeine-GI upset only, who on 01-OCT-2007 was vaccinated intramuscularly in the right arm with a first dose of PNEUMOVAX 23 vaccine (Lot# 658555/0964U). There was no concomitant medication. On 02-OCT-2007 at 08:40 (previously reported as 01-OCT-2007) the patient developed a 100F temperature, experienced generalized body aches, flu-like symptoms, a hot arm, dizziness, fatigue, and the injection site of the right arm became swollen and painful. The patient notified the physician's office by phone and was instructed to apply ice and to take BENADRYL. No laboratory diagnostics were performed. A follow up examination was scheduled for 04-OCT-2007. The patient recovered on approximately 10-OCT-2007. No product quality complaint was involved. Additional information is not expected.
temperature excursion which was administered to multiple patients.; No additional AE's reported.; This spontaneous report was received from a registered nurse referring to a patient of unknown gender and age.  The reporter did not provide information on the patient's historical drugs or reactions, pertinent medical history and concomitant medications.  On 08-APR-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) with dose reported as 1 administered subcutaneously (lot number T028303 and expiration date 20-AUG-2022) for prophylaxis (vaccination scheme frequency and anatomical location were not reported). It was stated that the vaccine was administered after temperature excursion (incorrect product storage). It was reported that the vaccine reached a temperature of minus 11.5 degree Celsius. This excursion had a time frame reported of 25 minutes. No previous excursions were reported, and information was provided via data logger. No additional adverse event was reported and patient was asymptomatic.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2104USA002751:
Sore arm that same day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm that same day) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore arm that same day). At the time of the report, VACCINATION SITE PAIN (Sore arm that same day) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Patient wants to go to the dentist and she's going to be administered anesthesia, also probably she's going to be taking some pain medicine afterwards.  Treatment information was not provided.
30yo female with allergies to PCN (hives), bee stings (hives), latex (rash), and kiwi/citrus (swelling/tingling of tongue), was vaccinated with COVID10 Pfizer BioNTech dose#2 and reported a racing heart and chest tightness. No SOB nor difficulty breathing.  No lip swelling nor scratchy throat.  No antidote nor supportive treatment given. Symptoms resolved within the observation period.    Of note, after dose#1 patient had c/o feeling warm, blotchy across her face and chest and being nervous which resolved. Reported to VAERS on 1/20/21 (#249700).
Facial weakness and diffuse pain and muscle weakness.  12/22/09 and 12/23/09 Hospital records, discharge summary received. Service dates 12/17/09 to 12/22/09. Assessment: Guillain-Barre syndrome, ataxia, Streptococcal pharyngitis, right facial palsy, constipation.  Patient admitted for facial droop, slurred speech, muscle weakness, joint pains. VII CN weakness on (R). Bell's Palsy. Mild lower extremity weakness. Polydipsia, polyuria. Eczematous lesions on limbs. IVIG administration with improvement. Complaints of pain.  12/18/09 Neurology consult received. Service date 12/17/09. Assessment: Post infectious weakness of the limbs and Bell's palsy (R). Patient presented with drooping of face, unsteady gait. and generalized body pain.  12/23/09 PCP Medical records received. Service dates 9/25/09 to 12/22/09. Assessment: Bell's Palsy Guillain-Barre syndrome. 12/10/09 shaky, tremors. Post hospitalization presents with continued drooling. To have physical therapy.
No side effects reported.; Vaccine administered experienced a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information about patient's medical history, concurrent conditions and concomitant medications was provided.   On 21-JUN-2023, the patient was vaccinated with improperly dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot #W026137, expiration date 05-FEB-2024, exact dose and route of administration were not provided) for prophylaxis (Product storage error).  On unknown day, the suspect vaccine experienced a temperature excursion of 8.74 degrees Celsius (C) for 35 minutes. There was no previous temperature excursion. No side effects reported (No adverse event). No other medical information known. No product quality complaint (PQC).  This is one of several reports received from the same reporter.
After obtaining consent, and per orders of Dr., injection of Bexsero, HPV given by LPN. Patient instructed to remain in clinic for 20 minutes afterwards, and to report any adverse reaction to me immediately.    Patient did pass out for about 4 seconds with some convulsions. He was eased to the floor when he came too. Then he decided he would like to lay down on the floor, felt that like he could vomit. He was given a cold compress and was then brought to the table to lay down with feet, was give water and monitored. Within 5 min of passing out his BP was checked and it was 108/54 left arm while laying on the floor. Pulse was 54. After sitting you his pulse increase to 88 and BP 110/70.
early evening low grade temp-arm hurting, crying w/pain;AM woke up t103, lethargic, glazed eyes;severe cough, vomited; asthmatic; bronchitis;
Noticed swelling and redness when they got home from appointment. it began to worsen that day had localized swelling up to 4in in diameter. no fevers no nausea/vomiting. she c/o mild pain to touch. no HA no neck pain no changes in vision.  recommending ice ibuprofen Tylenol as needed.
This spontaneous report as received from a pharmacist referring to an unspecified patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unspecified date, the patient may have received an improperly stored dose of VARIVAX (lot # N015475, expiration date 18-MAY-2019; dose and route of administration were not reported) for prophylaxis (product storage error). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit for 36 hours. Data logger was not involved. There were no previous excursions reported. Follow up information has been received from the pharmacist on 07-FEB-2018 referring the 33 years old male patient. On 03-JAN-2018, the patient was vaccinated with the first dose of VARIVAX vial subcutaneously in left side (location was not provided), which was reconstituted with sterile diluent (manufacturer unknown). On the same day, the patient also received the first dose of BOOSTRIX (0.5 ml, lot# TB2R2; expiration date unknown) intramuscularly in left side (location was not provided) for prophylaxis. The sterile diluent (manufacturer unknown) had been out from fridge nearly 3 days before being used for vaccination. The reporter had been confirmed the product was good at room temperature for 7 days.
pt recv vax;started lesions 19jul95;on 7aug, still getting lesions, approx 20 all together;prolonged gen eruption p/vax
Nausea/vomiting Vertigo motor coordination fatigue Veins pronounced in lower legs
02/05/22 presents to ED for "Altered Mental Status". PMHx of "migraine headaches, recent Covid-19 infection, seasonal allergies, exercise-induced asthma"
Woke up next morning pain left side. Headache front and back of head. Fatigued, pain when touch left side, Nausea and constipation , Rash on left
Broad area of patchy redness on left thigh with a needle mark visible at the superior border of the reddened area. About 5-6cm involvement but nontender, no streaking, minimal if any warmth.
Tiredness; Lump in left armpit, noticed 30-32 hours after vaccination; Soar arm,; acute pain in left arm and extend to neck; (Very strong pain in left arm started 3 or 4 hours after the shot and lasted 48 hours; Area of shot swelled; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247), via intramuscular route, administered in Arm Left on 22Mar2021 10:15 (at the age of 52-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Retina's detachment both eyes with surgeries (2 surgeries 2004 and 2013), cataract (2013- 2015), appendicitis (Surgery in 1986), silent reflux, white blood cell count (Regular checks on an annual basis with haematologist). Family history included Prostate Cancer, cholesterol increased, Fibrosis (Lung fibrosis) (father) and Arthritis Rheumatoid, atherosclerosis, Glaucoma (Mother). Patient did not have any illness at time of vaccination. Concomitant medication(s) included pantoprazole sodium taken for gastrooesophageal reflux disease, start and stop date were not reported; monascus purpureus (RED RICE) taken for blood cholesterol, start and stop date were not reported. Patient was not pregnant at the time of vaccination. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL3247) via intramuscular route, administered in Arm Left on 01Mar2021 09:30 (at the age of 52-year-old) as DOSE 1, SINGLE for covid-19 immunisation and experienced Sore arm, menstruation five days after shot. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination included Pantoprazole; Red rice for cholesterol. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 22Mar2021 13:00, the patient experienced tiredness, lump in left armpit noticed 30-32 hours after vaccination; sore arm, acute pain in left arm and extended to neck. Very strong pain in left arm started 3 or 4 hours after the shot and lasted 48 hours. Area of shot swelled. The patient underwent lab tests and procedures which included blood test: positive on Dec2020, polymerase chain reaction: negative on 16Jun2020, negative on 20Sep2020, negative on 26Nov2020, negative on 23Jan2021. Patient did not receive treatment for adverse events. The outcome of all events was recovering.   Follow-up attempts are completed. No further information is expected; Sender's Comments: Linked Report(s) : -PFIZER INC-2021244974 similar report from same reporter